Manikhandan A. V. Mudaliar (Preferred)
Manikhandan A. V. Mudaliar
Director, Quantitative Biomarkers, Clinical Development, Recursion
Joined
May 2025
Names
Emails
****@recursion.com (Confirmed)
****@gmail.com (Confirmed)
Personal Links
Career & Education History
Director, Quantitative Biomarkers
Clinical Development, Recursion (recursion.com)
2024 – Present
Director, Quantitative Biomarkers
Early Development, Exscientia (exscientia.co.uk)
2024 – 2024
Director, Target Discovery
Bioinformatics, Exscientia (exscientia.co.uk)
2021 – 2024
Head of Bioinformatics
Bioinformatics, Summit Therapeutics (smmttx.com)
2021 – 2021
Principal Scientist (Bioinformatics)
Bioinformatics, Cerevance (cerevance.com)
2018 – 2021
Head Bioinformatician
Bioinformatics, University of Glasgow (glasgow.ac.uk)
2016 – 2018
Bioinformatician
Bioinformatics, University of Glasgow (glasgow.ac.uk)
2012 – 2016
Bioinformatics Analyst
Bioinformatics, University of Dundee (dundee.ac.uk)
2011 – 2016
Bioinformatics Analyst
Bioinformatics, Pfizer Inc. (pfizer.com)
2010 – 2011
Veterinary Surgeon
Animal Husbandry, Government of Tamil Nadu (it.tn.gov.in)
2001 – 2010
Advisors, Relations & Conflicts
Expertise
Artificial intelligence in drug discovery and development
2021 – Present
Machine Learning for drug discovery and development
2010 – Present
Bioinformatics for drug discovery
2008 – Present